[ Price : $8.95]
PharmaTher says it will work with FDA toward a Phase 3 trial of its ketamine infusion to treat levodopa-induced dyskinesia in Park...[ Price : $8.95]
CDER Office of Manufacturing Quality branch chief Maan Abduldayem outlines the Centers Top Recent Warning Letter Citations (FY 201...[ Price : $8.95]
Federal Register notice: FDA renews its Obstetrics, Reproductive and Urologic Drugs Advisory Committee for an additional two years...[ Price : $8.95]
FDA clears an Artio Medical 510(k) for its Solus Gold Embolization Device for peripheral vascular occlusion.[ Price : $8.95]
FDA issues a complete response letter saying it cannot approve at this time a Takeda prior approval supplement for its Natpara hyp...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Certain Ophthalmic Products: Policy Regarding Compliance Wi...[ Price : $8.95]
Pfizer recalls branded and authorized generic lots of Accuretic tablets due to the presence of a nitrosamine above the acceptable ...[ Price : $8.95]
FDA warns Fort Lauderdale, FL-based ECI Pharmaceuticals about listing violations for two estrogen products that have been removed ...